Sequential versus concurrent paclitaxel and carboplatin for the treatment of advanced non-small cell lung cancer in elderly patients and patients with poor performance status: results of two Phase II, multicenter trials
- 1 January 2005
- journal article
- clinical trial
- Published by Elsevier in Lung Cancer
- Vol. 47 (1) , 111-120
- https://doi.org/10.1016/j.lungcan.2004.06.002
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- Weekly Carboplatin and Paclitaxel in Elderly Non–Small-Cell Lung Cancer Patients (≥65 Years of Age)American Journal of Clinical Oncology, 2003
- Curative approaches to lung cancer in the elderlySeminars in Surgical Oncology, 2003
- Multicenter, Randomized Trial for Stage IIIB or IV Non–Small-Cell Lung Cancer Using Weekly Paclitaxel and Carboplatin Followed by Maintenance Weekly Paclitaxel or ObservationJournal of Clinical Oncology, 2003
- Chemotherapy Options for the Elderly Patient with Advanced Non-Small Cell Lung CancerThe Oncologist, 2003
- Lung Cancer in the ElderlyDrugs & Aging, 2002
- Treatment and Outcomes for Elderly Patients with Small Cell Lung CancerDrugs & Aging, 2000
- Chemotherapy in non-small cell lung cancer: a meta-analysis using updated data on individual patients from 52 randomised clinical trialsBMJ, 1995
- Chemotherapy vs Supportive Care in Advanced Non-Small-Cell Lung CancerChest, 1994
- Polychemotherapy in advanced non small cell lung cancer: a meta-analysisThe Lancet, 1993
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958